81 related articles for article (PubMed ID: 8472118)
21. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
22. Definitive radiotherapy for carcinoma in situ of the true vocal cords.
Sengupta N; Morris CG; Kirwan J; Amdur RJ; Mendenhall WM
Am J Clin Oncol; 2010 Feb; 33(1):94-5. PubMed ID: 19738453
[TBL] [Abstract][Full Text] [Related]
23. Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial.
Roberts SA; Hendry JH; Swindell R; Wilkinson JM; Hunter RD
Radiother Oncol; 2004 Jan; 70(1):63-74. PubMed ID: 15036854
[TBL] [Abstract][Full Text] [Related]
24. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
[TBL] [Abstract][Full Text] [Related]
25. Further analysis of radiobiological parameters from the First and Second British Institute of Radiology randomized studies of larynx/pharynx radiotherapy.
Chappell R; Nondahl DM; Rezvani M; Fowler JF
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):509-18. PubMed ID: 7673041
[TBL] [Abstract][Full Text] [Related]
26. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
27. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
[TBL] [Abstract][Full Text] [Related]
28. A comparative review of the Hammersmith (1971-75) and Edinburgh (1977-82) neutron therapy trials of certain cancers of the oral cavity, oropharynx, larynx and hypopharynx. Medical Research Council Neutron Therapy Working Group.
Br J Radiol; 1986 May; 59(701):429-40. PubMed ID: 3518846
[TBL] [Abstract][Full Text] [Related]
29. Local-regional control by conventional radiotherapy according to tumor volume in patients with squamous cell carcinoma of the pharyngolarynx.
Kawashima M; Ogino T; Fujii H; Ishikura S; Ito Y; Ikeda H
Jpn J Clin Oncol; 1999 Oct; 29(10):467-73. PubMed ID: 10645800
[TBL] [Abstract][Full Text] [Related]
30. [Timing and duration of postoperative radiotherapy in patients with laryngeal cancer].
Milecki P; Kruk-Zagajewska A; Stryczyńska G
Otolaryngol Pol; 2002; 56(3):307-11. PubMed ID: 12162018
[TBL] [Abstract][Full Text] [Related]
31. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada.
Hendry JH; Roberts SA; Slevin NJ; Keane TJ; Barton MB; Agren-Cronqvist A
Radiother Oncol; 1994 Apr; 31(1):14-22. PubMed ID: 8041895
[TBL] [Abstract][Full Text] [Related]
32. Results of radiotherapy of carcinoma laryngis in relation to the mode of dose fractionation.
Durkovský J; Sevcíková L; Miklánková M
Neoplasma; 1981; 28(5):599-609. PubMed ID: 7312078
[TBL] [Abstract][Full Text] [Related]
33. [Radiation and chemoradiation therapy of malignant laryngopharyngeal tumors].
Morozov AI; Rogachikova TA; Korshunov AI; Biriukov VA; Pinskaia LG
Med Radiol (Mosk); 1985 Aug; 30(8):15-8. PubMed ID: 4033383
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors and results of external irradiation of cancers of the base of the tongue].
Jaulerry C; Bataini JP; Brunin F; Rodriguez J; Brugère J
Ann Otolaryngol Chir Cervicofac; 1985; 102(7):519-24. PubMed ID: 3937474
[TBL] [Abstract][Full Text] [Related]
35. First interim progress report on the second British Institute of Radiology Fractionation Study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngopharynx.
Wiernik G; Alcock CJ; Bates TD; Berry RJ; Brindle JM; Dalby JE; Fowler JF; Gajek WR; Goodman S; Haybittle JL
Br J Radiol; 1989 May; 62(737):450-6. PubMed ID: 2653552
[TBL] [Abstract][Full Text] [Related]
36. Radiation of jejunal interposition in T3-T4 upper aerodigestive tumours.
Handl-Zeller L; Hohenberg G; Grasl M; Stanek C; Piza H; Roka R; Ehrenberger K
Eur J Cancer; 1992; 28(1):50-3. PubMed ID: 1567691
[TBL] [Abstract][Full Text] [Related]
37. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy of T1 and T2 glottic cancer: analysis of anterior commissure involvement.
Hirota S; Soejima T; Obayashi K; Hishikawa Y; Honda K; Okamoto Y; Maeda H; Takada Y; Inoue K; Kinishi M; Amatsu M; Kimura S
Radiat Med; 1996; 14(6):297-302. PubMed ID: 9132809
[TBL] [Abstract][Full Text] [Related]
39. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
[TBL] [Abstract][Full Text] [Related]
40. Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx.
Maciejewski B; Taylor JM; Withers HR
Radiother Oncol; 1986 Dec; 7(4):323-6. PubMed ID: 3809591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
